Medasense
Medasense offers a breakthrough technology that enables clinicians to optimize and personalize pain control and avoid overmedication.
Total raised
€15M
€15,372,000
Funding rounds
1
Investors
0
distinct backers
Active since
2020-09
latest 2020-09
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood20
base rate 51% for Series C
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-22 | Series C | €15M | — | View deal → |
Related news
Similar companies
same sector or country- DAZN€3.8BUK · Software
- Visma€3.0BNorway · Software
- Celonis€2.1BGermany · Software
- Bending Spoons€1.7BItaly · Software
- UiPath€1.7BRomania · AI
- ContentSquare€1.3BFrance · Software